Volume : 09, Issue : 05, May – 2022
Title:
68.UNDERSTANDING THE IMPLICATIONS OF METABOLIC SYNDROME ON OVERALL HEALTH AND DISEASE RISK.
Authors :
Eman Salman Alsafwani, Fatimah Mohammed Al-Hay, Talal Mohammed ALShammari, Salman Mohammed Harthi, Haya Fahad ALSuwailem, Rajjaa Hussain Al Adam, Khadija Ali Alkhamis, Najwa Saleh Salah Aljehani,Bashaer Ahmed Mahnashi, Naflah Ibrahim Aldossari
Abstract :
Background: MetS is a significant public health concern characterized by a cluster of metabolic disturbances, including obesity, hypertension, dyslipidemia, and insulin resistance. This condition substantially increases the risk of developing serious health issues such as cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). Understanding its implications is crucial for effective management and prevention strategies.
Aim: This overview explores the importance of early detection, effective management strategies, and the impact of MetS.
Methods: This is a comprehensive review using PUBMED and Google Scholar as primary databases for articles collected until 2021.
Conclusion: MetS poses a serious health threat, requiring a comprehensive strategy for diagnosis and treatment that emphasizes lifestyle changes and possible medication to lower the risks of heart disease and diabetes. Effective diagnostic methods include measuring waist circumference, assessing blood pressure, and evaluating glucose and cholesterol levels, which help in early detection and management of the syndrome.
Keywords: MetS – Diagnosis – Management – Impact
Cite This Article:
Please cite this article in Eman Salman Alsafwani et al, Understanding The Implications Of Metabolic Syndrome On Overall Health And Disease Risk , Indo Am. J. P. Sci, 2022; 09 (05).
Number of Downloads : 10
References:
1. Grundy SM. Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds. Journal of the American College of Cardiology. 2006;47(6):1093-100.
2. BORCH JK. THE METABOLIC SYNDROME IN A GLOBAL PERSPECTIVE. THE PUBLIC HEALTH IMPACT-SECONDARY PUBLICATION. 2007.
3. Pacholczyk M, Ferenc T, Kowalski J. The metabolic syndrome. Part I: definitions and diagnostic criteria for its identification. Epidemiology and relationship with cardiovascular and type 2 diabetes risk. Postepy Higieny i Medycyny Doswiadczalnej (Online). 2008;62:530-42.
4. Jørgensen ME, Borch-Johnsen K. The metabolic syndrome—is one global definition possible? Diabetic Medicine. 2004;21(10):1064-5.
5. P. A, Nugent. The metabolic syndrome. Nutrition Bulletin. 2004;29(1):36-43.
6. Fulop T, Tessier D, Carpentier A. The metabolic syndrome. Pathologie Biologie. 2006;54(7):375-86.
7. Alberti G. Introduction to the metabolic syndrome. European Heart Journal Supplements. 2005;7(suppl_D):D3-D5.
8. Roman G, Hancu N. Metabolic syndrome–new insights into a growing entity. Romanian Journal of Internal Medicine= Revue Roumaine de Medecine Interne. 2004;42(2):257-66.
9. Amihaesei IC, Chelaru L. Metabolic syndrome a widespread threatening condi-tion; risk factors, diagnostic criteria, therapeutic op-tions, prevention and controversies: an overview. The Medical-Surgical Journal. 2014;118(4):896-900.
10. Chanda H, Kelly P, Andrews B, Siziya S, Lakhi S. Predictive value of Metabolic Syndrome components in detecting the syndrome in patients with type 2 Diabetes Mellitus. Medical Journal of Zambia. 2010;37(3):130-5.
11. Parish RC, Huang J, Mansi I. Screening for the Metabolic Syndrome in a Public Care Hospital Clinic Population a Simple Measurement of Waist Circumference. Journal of Investigative Medicine. 2011;59(1):22-6.
12. Roĭtberg G, Ushakova T, Sharkhun O, ZhV D. The integrated approach to diagnostics of metabolic syndrome in clinical practice. Kardiologiia. 2012;52(10):45-50.
13. Mahjoub S, Ahmadi MH, Faramarzi M, Ghorbani H, Moazezi Z. The prevalence of metabolic syndrome according to the Iranian Committee of Obesity and ATP III criteria in Babol, North of Iran. Caspian journal of internal medicine. 2012;3(2):410.
14. Trujillo-Hernández B, Trujillo-Magallón E, Trujillo-Magallón M, Brizuela-Araujo CA, García-Medina MA, González-Jiménez MA, et al. Frecuencia del síndrome metabólico y factores de riesgo en adultos con y sin diabetes mellitus e hipertensión arterial. Revista de Salud Pública. 2017;19:609-16.
15. Artanti KD, Martini S, editors. METABOLIC SYNDROME RISK FACTORS IN EMPLOYEES FACULTY OF PUBLIC HEALTH, UNIVERSITAS AIRLANGGA. Proceedings of the International Conference on Public Health; 2017.
16. Schweiger C, Cirrincione V, Ignone G. Metabolic syndrome: a true syndrome or only a cluster of risk factors? Giornale Italiano di Cardiologia (2006). 2008;9(4 Suppl 1):67S-73S.
17. C Fernandez-Garcia J, Cardona F, J Tinahones F. Inflammation, oxidative stress and metabolic syndrome: dietary modulation. Current Vascular Pharmacology. 2013;11(6):906-19.
18. Hoerger TJ, Ahmann AJ. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes. Journal of Managed Care Pharmacy. 2008;14(1 Supp B):1-18.
19. Dumas M-E, Emanueli C. Circulating microRNAs to predict the risk for metabolic diseases in the general population. Diabetes. 2017;66(3):565-7.
20. Villarini M, Lanari C, Barchiesi L, Casciari E, Tabascio A, Castellini M, et al. Copia esclusiva per: Prof. Massimo Moretti. Ann ig. 2015;27:595-606.
21. Group DPPR. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes care. 2005;28(4):888-94.